J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement for Book Closure / Record Date

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of unaudited consolidated financial results for quarter ended on December 31, 2020

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about virtual Analysts/Institutional Investor Meet on March 02, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 10, 2021, titled "Press Release on Q3 / FY 2021 Financial Results.".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Feb-2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Mayank Mishra as Non- Executive Director of the company w.e.f. February 10, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Gaurav Trehan as Non- Executive Director of the company w.e.f. February 10, 2021.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 10, 2021, declared Interim Dividend of 8.50 per equity share.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 10, 2021.

Board to consider declaration of Interim Dividend

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA Approval by US FDA'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Result of Postal Ballot '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

Disclosure of related party transactions under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the first half of the financial year 2020-21 of the Company

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisement for Postal Ballot

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Issue of Postal Ballot Notice '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about -Newspaper cutting of extract of unaudited consolidated financial results for quarter ended on September 30, 2020

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about issue of duplicate share certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2020, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company - Appointment of Auditor .

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company - Resignation of Auditor .

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company - Resignation of a director .

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 10, 2020.

Promoter of JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Disclosures of reasons for encumbrance under SEBI SAST Regulations, 2011.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Ajay Candade as Non- Executive Director of the company w.e.f. October 05, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Nikhil Chopra as Whole-time Director & Chief Executive Officer of the company w.e.f. October 05, 2020.

ICICI Securities Limited has informed the Exchange about Post Offer Public Announcement of J.B. Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2020. Further, the company has informed the Exchange regarding voting results.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2020

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 15, 2020, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on September 14, 2020.

JICICI Securities Limited has submitted to the Exchange a copy of Pre Offer Advertisement in Accordance with Regulations 18(7) of the Securities and Exchange Board of India ( Substantial Acquisition of Shares and Takeovers) Regulations 2011 as Amended and Corrigendum to the Detailed Public Statement for the Attention of the Public Shareholders of J B Chemicals and Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Newspaper publication'.

JB Chemicals & Pharmaceuticals Limited had intimated the 17-Sep-2020 as the record date. The Company has now informed the Exchange that the Record date has been revised to 23-Sep-2020 for the purpose of Dividend.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the revised date of Annual General Meeting is September 30, 2020

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a copy of advertisement published on September 5, 2020 in furtherance to their Letter of Offer dated September 4, 2020

ICICI Securities Limited has submitted to the Exchange a copy of Letter of Offer JB Chemicals & Pharmaceuticals Limited Target Company.

Tau Investment Holdings Pte Ltd has submitted to the Exchange a copy of disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Resignation of Independent Directors'.